July 2018 FDA Recall Fluocinolone Acetonide Topical by Teva Pharmaceuticals Usa
D-0909-2018 - Failed Impurities and Degradation Specifications and Subpotent Drug

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on July 5, 2018 for the product Fluocinolone Acetonide Topical. The FDA reported the reason for recall as failed impurities and degradation specifications and subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0909-2018

Reason for Recall
Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.
Initiated
07-05-2018
Reported
07-18-2018
Quantity
27,803 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
Nationwide in the USA and Puerto Rico
Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL bottle, Rx Only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108 USA; Distributed by: Actavis Pharmac, Inc., Parsippany, NJ 07054 USA, NDC 0591-2990-60.

Batch or Lot Expiration Information

Lot# s: 1164898, EXP 10/18; 1164904, 1164909, EXP 11/18; 1211396, EXP 07/19; 1230808, 1231127, EXP 01/20

Affected Packages Involved in this Recall